Treatment of Parkinson's disease using cell transplantation.

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

Sammanfattning

The clinical trials with intrastriatal transplantation of human fetal mesencephalic tissue, rich in dopaminergic neurons, in Parkinson's disease (PD) patients show that cell replacement can work and in some cases induce major, long-lasting improvement. However, owing to poor tissue availability, this approach can only be applied in very few patients, and standardization is difficult, leading to wide variation in functional outcome. Stem cells and reprogrammed cells could potentially be used to produce dopaminergic neurons for transplantation. Importantly, dopaminergic neurons of the correct substantia nigra phenotype can now be generated from human embryonic stem cells in large numbers and standardized preparations, and will soon be ready for application in patients. Also, human induced pluripotent stem cell-derived dopaminergic neurons are being considered for clinical translation. Available data justify moving forward in a responsible way with these dopaminergic neurons, which should be tested, using optimal patient selection, cell preparation and transplantation procedures, in controlled clinical studies.
Originalspråkengelska
Artikelnummer20140370
TidskriftPhilosophical Transactions of the Royal Society B: Biological Sciences
Volym370
Nummer1680
DOI
StatusPublished - 2015

Ämnesklassifikation (UKÄ)

  • Neurologi

Fingeravtryck

Utforska forskningsämnen för ”Treatment of Parkinson's disease using cell transplantation.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här